Galapagos to present results of pioneering innovation in cancer cell therapy at ash 2024

Mechelen, belgium; november 5, 2024, 22:01 cet; galapagos nv (euronext & nasdaq: glpg) today announced that it will present new data from its car t- and tcr t-cell therapy pipeline at the 66 th american society of hematology (ash) annual meeting and exposition in san diego, ca, 7-10 december 2024.
ASH Ratings Summary
ASH Quant Ranking